Compugen (CGEN) EBT Margin Growth (3y) (2012 - 2025)

Compugen (CGEN) EBT Margin Growth (3y) (2012 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 9,237.00
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 441.00
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -408.00
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -120.00
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Compugen 215.59 Mn 123.84 Mn 352,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2025 12,488.00
Dec 31, 2023 48,410.00
Sep 30, 2018 290,422.00
Dec 31, 2016 -1.59 Mn
Sep 30, 2016 -1.08 Mn
Jun 30, 2016 1.25 Mn
Mar 31, 2016 -709,180.00
Dec 31, 2015 400,872.00
Sep 30, 2015 30,590.00
Dec 31, 2013 106,501.00
Jun 30, 2013 -1.37 Mn
Mar 31, 2013 -27,251.00
Dec 31, 2012 379,430.00
Sep 30, 2012 -535,833.00